$291 Million is the total value of Eagle Health Investments LP's 29 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IQV | Sell | IQVIA HLDGS INC | $20,664,000 | +6.8% | 85,277 | -14.9% | 7.09% | -6.6% |
| NTRA | Sell | NATERA INC | $18,527,000 | +8.4% | 163,194 | -3.1% | 6.36% | -5.3% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $14,143,000 | -25.6% | 70,144 | -20.7% | 4.85% | -35.0% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $12,979,000 | -29.1% | 235,513 | -33.6% | 4.45% | -38.0% |
| DFHT | Exit | DEERFIELD HEALTHCARE TECH AC | $0 | – | -340,075 | -100.0% | -1.62% | – |
| JWS | Exit | JAWS ACQUISITION CORP | $0 | – | -496,100 | -100.0% | -2.58% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DELput | $0 | – | -50,000 | -100.0% | -3.28% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -20,951 | -100.0% | -3.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.